| 591 |
C-REACTIVE PROTEIN , INSULIN RESISTANCE, AND ENDOTHELIAL DYSFUNCTION MARKERS IN HEALTHY OBESE SUBJECTS. |
2004 |
| 592 |
C-REACTIVE PROTEIN , INSULIN RESISTANCE, AND ENDOTHELIAL DYSFUNCTION MARKERS IN HEALTHY OBESE SUBJECTS. |
2004 |
| 593 |
Different tools to assess the mediastinum in patients with intrathoracic lesions |
2004 |
| 594 |
Evaluation of bone turnover in seronegative spondyloarthropathy: relationship to disease activity. |
2004 |
| 595 |
Hepatitis E virus antibodies in multiply transfused patients. |
2004 |
| 596 |
HOMOCYSTENINE AND VON WILLEBRAND FACTOR IN TYPE II DIABETES MELLITUS. |
2004 |
| 597 |
INFLAMMATORY MEDIATORS IN PLASMA AND PERITONEAL FLUID IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS . |
2004 |
| 598 |
Soluble Fas as an apoptotic marker in myocardial infarction, the outcome and its relation to high risk clinical features |
2004 |
| 599 |
Soluble Fas as an apoptotic marker in myocardial infarction, the outcome and its relation to high risk clinical features |
2004 |
| 600 |
Study of intestinal flow by combined videofluoroscopy, manometry, and multiple intraluminal impedance. |
2004 |